Volume 28, Issue 2 (Iran South Med J 2025)                   Iran South Med J 2025, 28(2): 576-589 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Daneshfard M, Morovati sharifabad M, Salehi E, Dehestani ardakani M, Rezai-golmishe A. Histomorphological Changes in the Fetal Rat Liver Following Exposure to Valacyclo-vir. Iran South Med J 2025; 28 (2) :576-589
URL: http://ismj.bpums.ac.ir/article-1-2269-en.html
1- Department of Basic Sciences, School of Veterinary Medicine, Ardakan University, Ardakan, Iran
2- Department of Basic Sciences, School of Veterinary Medicine, Ardakan University, Ardakan, Iran , mmorovati@ardakan.ac.ir
3- Department of Basic Sciences, School of Veterinary Medicine, Tehran University, Tehran, Iran
Abstract:   (180 Views)
Background: Herpesviruses, a family of DNA viruses, cause various infections in humans and animals, affecting the skin and internal organs. Valacyclovir, a prodrug of acyclovir, is an effective antiviral drug widely used to treat diseases caused by herpesviruses. Importantly, valacyclovir can easily cross the placental barrier during pregnancy. This raises concerns about potential harmful effects on fetal development. Therefore, this study aimed to examine the effects of valacyclovir on the development of fetal liver tissue in pregnant rats.
Materials and Methods: Twenty-four pregnant Wistar rats were randomly divided into four groups of six. The control group received no treatment. The experimental groups were given oral valacyclovir daily at doses of 100, 200, or 300 mg/kg during pregnancy. Maternal weights were recorded at the start and end of the study. On day 20 of gestation, rats were euthanized. Blood samples were collected for biochemical tests, including ALT, AST, ALP, MDA, and TAC. Fetal livers were fixed for histological studies.
Results: High doses of valacyclovir caused a decrease in maternal weight and number of fetuses. Serum ALT and MDA levels increased significantly, while TAC decreased. Histology showed structural damage in fetal liver at higher doses.
Conclusion: Valacyclovir exposure during pregnancy may negatively affect fetal liver development. Thus, its use during gestation requires caution and careful monitoring.
Full-Text [PDF 938 kb]   (220 Downloads)    
Type of Study: Original | Subject: Histology - Anatomy
Received: 2025/05/21 | Accepted: 2025/08/31 | Published: 2025/11/22

References
1. Lefkowitz EJ, Dempsey DM, Hendrickson RC, et al. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucleic Acids Res 2018; 46(D1): D708-D717. [DOI]
2. James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ 2020; 98(5): 315329. [DOI]
3. Majewska A, Mlynarczyk-Bonikowska B. 40 years after the registration of acyclovir: do we need new anti-herpetic drugs?. Int J Mol Sci 2022; 23(7): 3431. [DOI]
4. Shahar-Nissan K, Pardo J, Peled O, et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet 2020; 396(10253): 779-785. [DOI]
5. Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2019; 9(9): CD001869. [DOI]
6. Sheffield JS, Fish DN, Hollier LM, et al. Acyclovir concentrations in human breast milk after valaciclovir administration. Am J Obstet Gynecol 2002; 186(1): 100-102. [DOI]
7. Coen DM. Antiherpesviral DNA polymerase inhibitors.In:Lafemina RL. Antiviral research: strategies in antiviral drug discovery. Philadelphia: Willy, 2009. 1-8. [DOI]
8. Sadler TW. Establishing the embryonic axes: prime time for teratogenic insults. J Cardiovasc Dev Dis 2017; 4(3): 15. [DOI]
9. Fang H, Li Q, Wang H, et al. Maternal nutrient metabolism in the liver during pregnancy. Front Endocrinol (Lausanne) 2024; 15: 1295677. [DOI]
10. Mirzaei A, Mirzaei N, Mirzaei M, et al. Hepatoprotectivitve effect of Iranian grape seed and Jaft (a part of oak fruit) extracts against CCL4 induced-liver toxicity in rats. Iran South Med J 2011; 14(4): 230-239. [Article]
11. Karami M, Saeed Nia S, Ebrahimzadeh MA, et al. Study of therapeutic and histopathologic effects of corn silk's aqueous and metanolic extract against dosage induced by MDMA in isolated rat liver perfusion system. Iran South Med J 2014; 17(1): 21-32. [Article]
12. Stahlmann R, Klug S, Lewandowski C, et al. Prenatal tox- icity of acyclovir in rats. Arch Toxicol 1988; 61(6): 468- 479. [DOI]
13. Xing W, Gu L, Zhang X, et al. A metabolic profiling analysis of the nephrotoxicity of acyclovir in rats using ultra performance liquid chromatography/mass spectrometry. Environ Toxicol Pharmacol 2016; 46: 234-240. [DOI]
14. Helldén A, Lycke J, Vander T, et al. The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment. J Antimicrob Chemother 2006; 57(5): 945-949. [DOI]
15. Moore HL Jr, Szczech GM, Rodwell DE, et al. Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests. Fundam Appl Toxicol 1983; 3(6): 560-568. [Article]
16. Lu H, Han YJ, Xu JD, et al. Proteomic characterization of acyclovir-induced nephrotoxicity in a mouse model. PLoS One 2014; 9(7): e103185. [DOI]
17. Parivar K, Mohsenikouchesfahani H, Mohammadzadehasl B. Surveying Acyclovir side effects on developing embryos of Balb/C mice strain. MEDICAL SCIENCES 2006; 16 (4) :231-235. (Persien) [Article]
18. Shahat EH, El Shabaka HA, Zakaria I, et al. Adverse effects of therapeutic doses of sofosbuvir and ribavirin on the liver of the developing mice embryos. Egypt J Exp Biol (Zool) 2021; 17(1): 51-66. [DOI]
19. Hu Z, Zhou J, Han L, et al. Acyclovir alleviates insulin resistance via activating PKM1 in diabetic mice. Life Sci 2022; 304:120725. [DOI]
20. Kara A, Yakut S, Caglayan C, et al. Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach.Drug Chem Toxicol 2023; 46(3): 546-556. [DOI]
21. Prado NM, Messias GC, SANTOS GO, Nunes VS, Schinonni MI, Paraná R. Prospective monitoring of drug use: drug-induced liver injury in a primary healthcare center. Arquivos de Gastroenterologia 2019 Nov 7; 56(4): 390-3. [DOI]
22. Mamede JA, Oliveira-Filho RM, Mora OA, et al. Hepatic and renal effects of azidothymidine and acyclovir on pregnant rats. Clin Exp Obstet Gynecol 2000; 27(3-4): 227-230. [Article]
23. Shaban RK. Effect Of Ribavirin in Causing Phenotypic Abnormalities and Histological Lesions in Albino Rat Fetuses and The Protective Role of Ginger Root Aqueous Extract. Review of International Geographical Education Online 2021; 11(12): 657-668. [DOI]
24. Magdy M, El Ghareeb AE, Eldebss TM, et al. Investigation of the embryo-toxicity of the antiviral drug “Ribavirin” in Wistar rats during different gestation periods. Egyptian Journal of Basic and Applied Sciences 2023; 10(1): 396-409. [DOI]

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Iranian South Medical Journal

Designed & Developed by: Yektaweb